These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7841589)

  • 1. Comment: Ondansetron for treating nausea and vomiting in the poisoned patient.
    Forster ER; Palmer JL
    Ann Pharmacother; 1994 Oct; 28(10):1203-4. PubMed ID: 7841589
    [No Abstract]   [Full Text] [Related]  

  • 2. Ondansetron for treating nausea and vomiting in the poisoned patient.
    Reed MD; Marx CM
    Ann Pharmacother; 1994 Mar; 28(3):331-3. PubMed ID: 8193420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity.
    Sage TA; Jones WN; Clark RF
    Ann Pharmacother; 1993 May; 27(5):584-5. PubMed ID: 8347909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

  • 6. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
    Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F
    J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of life in oncology. Importance of optimal control of nausea/vomiting induced by antineoplastic agents].
    Soins; 1994 Oct; (589):23-4. PubMed ID: 7676292
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
    Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
    Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
    Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI
    Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851
    [No Abstract]   [Full Text] [Related]  

  • 10. [An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2276-81. PubMed ID: 8259839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer.
    Cole RM; Robinson F; Harvey L; Trethowan K; Murdoch V
    J Pain Symptom Manage; 1994 Jan; 9(1):48-50. PubMed ID: 7513334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetron: perioperative use of a serotonin receptor antagonist for the prevention and treatment of nausea and vomiting.
    Early TE; Charbonneau J; McKnight G; Jenkins P
    J Post Anesth Nurs; 1995 Dec; 10(6):320-3. PubMed ID: 8632370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron and cisplatin-induced nausea and vomiting.
    Hait WN
    N Engl J Med; 1990 Nov; 323(21):1485-6. PubMed ID: 2146502
    [No Abstract]   [Full Text] [Related]  

  • 14. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy.
    Stewart DJ; Dahrouge S; Coyle D; Evans WK
    J Clin Oncol; 1999 Jan; 17(1):344-51. PubMed ID: 10458253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron for postoperative nausea and vomiting.
    Woodward M; Gora ML
    Ann Pharmacother; 1993 Feb; 27(2):188-9. PubMed ID: 8439697
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness and economy of low-dose ondansetron.
    Walton SC; Koenig TJ
    Am J Health Syst Pharm; 1995 Mar; 52(5):546-7. PubMed ID: 7606564
    [No Abstract]   [Full Text] [Related]  

  • 17. Ondansetron usage in HIV positive patients: a pilot study on the control of nausea and vomiting in patients on high dose co-trimoxazole for Pneumocystis carinii pneumonia.
    Gompels M; McWilliams S; O'Hare M; Harris JR; Pinching AJ; Main J
    Int J STD AIDS; 1993; 4(5):293-6. PubMed ID: 8218517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron eliminates nausea and vomiting associated with prostacyclin in a patient awaiting lung transplantation.
    Lawhorn S; Lawhorn CD; Davison C
    J Heart Lung Transplant; 1997 Apr; 16(4):472-3. PubMed ID: 9154961
    [No Abstract]   [Full Text] [Related]  

  • 20. Ondansetron for postoperative nausea and vomiting: decisions in the absence of comparative trials.
    Lewis MA; Fishman DA
    Am J Hosp Pharm; 1994 Feb; 51(4):524-5. PubMed ID: 8017423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.